LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$62.99 USD
-1.04 (-1.62%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $62.90 -0.09 (-0.14%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for LeMaitre Vascular, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 105 | 83 | 70 | 27 | 33 |
Receivables | 25 | 22 | 20 | 20 | 17 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 58 | 50 | 46 | 45 | 40 |
Other Current Assets | 6 | 7 | 4 | 3 | 3 |
Total Current Assets | 195 | 162 | 140 | 94 | 92 |
Net Property & Equipment | 22 | 18 | 17 | 15 | 15 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 1 | 2 | 2 | 2 | 1 |
Intangibles | 108 | 112 | 119 | 125 | 65 |
Deposits & Other Assets | 4 | 1 | 1 | 1 | 0 |
Total Assets | 347 | 310 | 293 | 253 | 188 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4 | 3 | 2 | 2 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 3 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 24 | 20 | 16 | 18 | 14 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 1 | 1 | 1 | 2 |
Total Current Liabilities | 30 | 25 | 22 | 25 | 21 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 36 | 14 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 2 | 3 | 5 | 4 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 49 | 42 | 39 | 80 | 40 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 201 | 189 | 182 | 115 | 106 |
Retained Earnings | 115 | 98 | 88 | 71 | 57 |
Other Equity | -5 | -6 | -3 | -2 | -4 |
Treasury Stock | 14 | 13 | 12 | 12 | 11 |
Total Shareholder's Equity | 298 | 268 | 254 | 173 | 148 |
Total Liabilities & Shareholder's Equity | 347 | 310 | 293 | 253 | 188 |
Total Common Equity | 298 | 268 | 254 | 173 | 148 |
Shares Outstanding | 22.20 | 22.00 | 21.80 | 20.30 | 19.90 |
Book Value Per Share | 13.42 | 12.19 | 11.66 | 8.50 | 7.44 |
Fiscal Year End for LeMaitre Vascular, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 105 | 97 | 90 | 81 |
Receivables | NA | 25 | 24 | 26 | 25 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 58 | 56 | 54 | 54 |
Other Current Assets | NA | 6 | 5 | 4 | 5 |
Total Current Assets | NA | 195 | 182 | 174 | 165 |
Net Property & Equipment | NA | 22 | 21 | 21 | 19 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 1 | 2 | 2 | 2 |
Intangibles | NA | 108 | 109 | 110 | 111 |
Deposits & Other Assets | NA | 4 | 3 | 3 | 2 |
Total Assets | NA | 347 | 334 | 326 | 315 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 4 | 4 | 4 | 3 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 24 | 22 | 19 | 18 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 1 | 1 |
Total Current Liabilities | NA | 30 | 29 | 26 | 24 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 2 | 2 | 2 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 49 | 45 | 43 | 41 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 201 | 198 | 197 | 192 |
Retained Earnings | NA | 115 | 110 | 106 | 101 |
Other Equity | NA | -5 | -7 | -6 | -6 |
Treasury Stock | NA | 14 | 13 | 13 | 13 |
Total Shareholder's Equity | NA | 298 | 289 | 284 | 274 |
Total Liabilities & Shareholder's Equity | NA | 347 | 334 | 326 | 315 |
Total Common Equity | 0 | 298 | 289 | 284 | 274 |
Shares Outstanding | 22.30 | 22.20 | 22.20 | 22.20 | 22.10 |
Book Value Per Share | 0.00 | 13.42 | 13.00 | 12.79 | 12.41 |